McDonald Weston E, Shorbaji Khaled, Kilcoyne Maxwell, Few William, Welch Brett, Hashmi Zubair, Kilic Arman
Department of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC, 29425, USA.
Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, 63130, USA.
Interdiscip Cardiovasc Thorac Surg. 2024 Jun 5;38(6). doi: 10.1093/icvts/ivae111.
The gold standard metric for centre-level performance in orthotopic heart transplantation (OHT) is 1-year post-OHT survival. However, it is unclear whether centre performance at 1 year is predictive of longer-term outcomes. This study evaluated factors impacting longer-term centre-level performance in OHT.
Patients who underwent OHT in the USA between 2010 and 2021 were identified using the United Network of Organ Sharing data registry. The primary outcome was 5-year survival conditional on 1-year survival following OHT. Multivariable Cox proportional hazard models assessed the impact of centre-level 1-year survival rates on 5-year survival rates. Mixed-effect models were used to evaluate between-centre variability in outcomes.
Centre-level risk-adjusted 5-year mortality conditional on 1-year survival was not associated with centre-level 1-year survival rates [hazard ratio: 0.99 (0.97-1.01, P = 0.198)]. Predictors of 5-year mortality conditional on 1-year survival included black recipient race, pre-OHT serum creatinine, diabetes and donor age. In mixed-effect modelling, there was substantial variability between centres in 5-year mortality rates conditional on 1-year survival, a finding that persisted after controlling for recipient, donor and institutional factors (P < 0.001). In a crude analysis using Kaplan-Meier, the 5-year survival conditional on 1-year survival was: low volume: 86.5%, intermediate volume: 87.5%, high volume: 86.7% (log-rank P = 0.52). These measured variables only accounted for 21.4% of the between-centre variability in 5-year mortality conditional on 1-year survival.
Centre-level risk-adjusted 1-year outcomes do not correlate with outcomes in the 1- to 5-year period following OHT. Further research is needed to determine what unmeasured centre-level factors contribute to longer-term outcomes in OHT.
原位心脏移植(OHT)中心水平表现的金标准指标是OHT术后1年生存率。然而,尚不清楚1年时的中心表现是否能预测长期预后。本研究评估了影响OHT长期中心水平表现的因素。
利用器官共享联合网络数据登记处确定2010年至2021年期间在美国接受OHT的患者。主要结局是OHT术后1年生存情况下的5年生存率。多变量Cox比例风险模型评估中心水平1年生存率对5年生存率的影响。混合效应模型用于评估结局的中心间变异性。
以1年生存为条件的中心水平风险调整后5年死亡率与中心水平1年生存率无关[风险比:0.99(0.97 - 1.01,P = 0.198)]。以1年生存为条件的5年死亡率预测因素包括受者为黑人种族、OHT术前血清肌酐、糖尿病和供者年龄。在混合效应模型中,以1年生存为条件的5年死亡率在各中心之间存在很大差异,在控制受者、供者和机构因素后这一发现仍然存在(P < 0.001)。在使用Kaplan-Meier的粗略分析中,以1年生存为条件的5年生存率为:低手术量中心:86.5%,中等手术量中心:87.5%,高手术量中心:86.7%(对数秩检验P = 0.52)。这些测量变量仅占以1年生存为条件的5年死亡率中心间变异性的21.4%。
中心水平风险调整后的1年结局与OHT术后1至5年的结局不相关。需要进一步研究以确定哪些未测量的中心水平因素对OHT的长期结局有影响。